Merck CEO says new pipeline is built to offset Keytruda's eventual patent expiration
- Posted on August 4, 2026
- By CNBC
- 0 Views
- 1 min read
In brief
Generating AI summary…
Merck CEO says new pipeline is built to offset Keytruda's eventual patent expiration
Merck CEO Rob Davis said the drugmaker has evolved beyond Keytruda, with more than 20 potential blockbuster launches over the next five years.
